PatternsRadar
Sign in

AJANTPHARMAjanta Pharma Limited

NSE
3,317.70INR+47.40 (+1.45%)Close · 20 Nov 2026
30 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹41,458 CrMarket cap
32.8P/E (TTM)
57.7%Delivery

Filings & corporate actions

80 results filed
CSV
Next results · Q3 FY27
Expected 30 Jan 2027 – 2 Feb 2027
Estimate: filed 30–33 days after quarter end, last 5 times
Dividend
₹32.00 per share · last 5 Aug 2026
2026
  • 30 OctresultsResults · Q2 FY27 · consolidated and standalone+1.4%NSE
  • 13 OctshareholdingShareholding · 30 Sept 2026-2.1%NSE
  • 5 AugdividendDividend · ₹32.00 per share-2.5%
  • 30 JulresultsResults · Q1 FY27 · consolidated and standalone+0.8%NSE
  • 14 JulshareholdingShareholding · 30 Jun 2026-0.4%NSE
  • 5 MayresultsResults · Q4 FY26 · consolidated and standalone+6.9%NSE
  • 13 AprshareholdingShareholding · 31 Mar 2026+3.3%NSE
  • 30 JanresultsResults · Q3 FY26 · consolidated and standalone+0.9%NSE
  • 12 JanshareholdingShareholding · 31 Dec 2025-1.3%NSE

Reaction to results · all yearsrose on day 0 in 52 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2730 Oct 2026+1.4%-4.4%—9.7×
Q1 FY2730 Jul 2026+0.8%+1.5%+3.5%1.9×
Q4 FY265 May 2026+6.9%+7.8%+1.7%9.3×
Q3 FY2630 Jan 2026+0.9%+2.5%+7.6%0.3×
Q2 FY263 Nov 2025+2.8%+1.1%+2.7%2.8×
Q1 FY2628 Jul 2025+2.0%-4.7%-9.4%0.7×
Q4 FY2530 Apr 2025-4.5%-6.2%-7.2%1.7×
Q3 FY2530 Jan 2025+0.7%+0.8%-7.1%2.5×
Q2 FY2529 Oct 2024+0.1%+6.5%+0.3%0.8×
Q1 FY2530 Jul 2024+6.5%+16.2%+24.5%4.8×
Q4 FY242 May 2024+6.7%+6.4%+4.4%29.2×
Q3 FY2431 Jan 2024+0.3%+1.3%+1.6%4.8×
Q2 FY2431 Oct 2023+3.6%+2.2%+12.1%3.7×
Q1 FY2427 Jul 2023+4.1%+12.5%+11.1%17.4×
Q4 FY235 May 2023-1.5%-2.1%+6.2%2.9×
Q3 FY232 Feb 2023+0.3%+1.6%-1.4%1.4×
Q2 FY234 Nov 2022-0.8%+1.9%-1.7%0.9×
Q1 FY2329 Jul 2022+0.5%+0.6%+7.7%2.4×
Q4 FY2211 May 2022+3.1%+2.9%+6.9%1.1×
Q3 FY2231 Jan 2022-1.1%-3.9%-20.8%0.7×
Q2 FY221 Nov 2021+4.2%+1.6%-1.9%1.7×
Q1 FY2230 Jul 2021-4.3%-4.1%-6.8%2.1×
Q4 FY211 May 2021-0.2%+9.2%+5.1%1.5×
Q3 FY213 Feb 2021+3.1%+2.5%0.0%7.3×
Q2 FY214 Nov 2020+0.3%-3.6%-0.9%4.7×
Q1 FY2131 Jul 2020+7.7%+12.0%+3.8%6.1×
Q4 FY2021 May 2020+3.4%+5.9%+0.9%5.8×
Q3 FY206 Feb 2020+8.9%+21.5%+21.4%6.6×
Q2 FY206 Nov 2019+1.0%-2.7%-2.5%3.3×
Q1 FY201 Aug 2019+8.4%+8.2%+15.6%8.1×
Q4 FY198 May 2019+0.6%-2.0%-5.3%0.4×
Q3 FY191 Mar 2019+0.8%+0.7%+5.5%0.7×
Q2 FY1921 Nov 2018-3.5%+1.8%-1.4%0.7×
Q1 FY197 Aug 2018+4.3%+4.4%+11.8%1.1×
Q4 FY1826 May 2018+5.1%-6.8%+4.2%1.3×
Q3 FY1816 Mar 2018+2.2%-1.2%-0.3%1.4×
Q2 FY181 Nov 2017-0.9%-2.6%+13.9%1.1×
Q1 FY1821 Aug 2017-4.3%-0.8%-0.7%1.9×
Q4 FY1715 May 20170.0%+2.6%-5.4%0.4×
Q3 FY1725 Jan 2017+1.2%+0.9%+1.6%1.2×
Q2 FY174 Nov 2016+2.1%-9.3%0.0%2.1×
Q1 FY1729 Sept 2016+0.1%-2.0%-0.3%0.5×
Q4 FY1629 Apr 2016-0.6%+2.0%+1.6%0.8×
Q3 FY163 Feb 2016+0.1%+0.9%+5.3%1.5×
Q1 FY1619 Nov 2015-0.5%-1.4%-4.6%0.7×
Q2 FY162 Nov 2015+0.7%-7.1%-11.1%0.5×
Q4 FY1519 May 2015+1.7%+10.2%+6.6%0.9×
Q3 FY155 Feb 2015-1.0%+2.3%+21.7%0.3×
Q2 FY153 Nov 2014-1.6%+13.0%+34.2%0.9×
Q1 FY1511 Aug 2014-1.7%+5.5%+12.0%0.3×
Q4 FY148 May 2014-4.5%-3.7%+9.7%0.8×
Q3 FY1429 Jan 2014-1.3%+0.6%+10.4%0.7×
Q2 FY146 Nov 2013+1.0%+5.3%+2.2%0.6×
Q1 FY142 Aug 2013-3.0%-3.6%-3.7%0.3×
Q4 FY1321 May 2013+5.3%+1.5%-1.9%1.6×
Q3 FY1323 Jan 2013+20.0%+54.7%+46.6%36.5×
Q2 FY1330 Oct 2012-3.7%-6.3%-8.7%1.2×
Q1 FY1319 Jul 2012+2.1%+0.6%+9.1%4.5×
Q4 FY123 May 2012+1.2%+2.0%+13.3%0.5×
Q3 FY1224 Jan 2012+6.8%+7.5%+28.0%7.7×
Q2 FY1224 Oct 2011-0.5%+2.9%-0.5%1.5×
Q1 FY1229 Jul 2011-0.8%-12.5%-13.6%0.7×
Q4 FY1130 Apr 2011+3.1%-0.4%+9.6%3.0×
Q3 FY1120 Jan 2011+19.2%+12.8%+7.3%65.3×
Q2 FY1122 Oct 2010+0.9%-5.1%-11.0%3.2×
Q1 FY1130 Jul 2010+2.4%-1.3%+16.6%1.0×
Q4 FY106 May 2010+0.3%-4.6%-2.0%1.0×
Q3 FY1029 Jan 2010-0.4%-0.4%+4.1%0.3×
Q2 FY1029 Oct 2009-3.5%-3.5%0.0%1.6×
Q1 FY1030 Jul 20090.0%-3.2%+3.8%0.6×
Q4 FY0915 May 2009+17.0%+42.0%+33.0%0.0×
Q3 FY0930 Jan 20090.0%+4.3%-3.3%0.3×
Q2 FY0923 Oct 2008+2.0%+1.0%-8.1%1.8×
Q1 FY0930 Jul 2008+3.5%+3.5%0.0%2.1×
Q4 FY0830 Apr 2008+5.5%+9.2%+1.2%3.1×
Q3 FY0830 Jan 2008+5.6%+7.7%+5.6%0.8×
Q2 FY0830 Oct 2007-0.6%-4.3%-0.6%0.5×
Q1 FY0830 Jul 2007-4.7%-8.9%-11.1%0.4×
Q4 FY0727 Apr 2007+6.8%+9.1%+11.4%8.4×
Average+1.9%+2.7%+4.0%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+32.5%
Profit YoY+49.2%
Interest cost YoY-43.1%
Revenue QoQ+10.3%
Profit QoQ+16.1%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+17.7%+16.8%+14.7%+14.6%+14.8%+15.6%
Profit+20.1%+24.1%+17.0%+12.4%+14.7%+18.4%

Key data

Open3,271.10
Day range3,260.60 – 3,325.00
52-week range2,445.80 – 3,796.00
From 52w high-12.6%
RSI (14)46.7
ATR (14)96.33
Volume84.2K
Avg volume (20D)1.84L
Rel volume0.46×
Volatility (1Y)25.9%
Turnover₹27.8Cr
Traded value (NSE)₹27.8Cr
VWAP3,303.58
SMA 50 / 2003,418.12 / 3,209.55
Price band20%

Delivery percentage

Latest · 20 Nov 202657.7%
20-day avg55.2%
1-year avg53.6%
Percentile (own history)81st
Range4.0–98.0%
Sessions3,629

Over the last 20 sessions AJANTPHARM settled 55.2% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 53.6%. The latest session ranks higher than 81% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.96%
Dividend, trailing 12M₹32.00
Paid every year for8 yr
Shareholders61.9K · -5.2% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy164 days ago

Performance returns

1D1W1M3M6M1Y
Price+1.45%+1.03%+1.44%-9.32%+5.35%+31.49%

Valuation

Market cap₹41,458 Cr
Market cap (NSE)₹41,458 Cr
Free-float cap₹15,144 Cr
P/E (TTM)32.8
P/E (NSE)32.4
EPS (TTM)101.06
P/B8.5
Net margin (TTM)20.3%
Other income / PBT11.5%
ROE27.5%
Debt / equity0.02
Shares outstanding12.54Cr
Listed29 May 2000

Ownership

Promoter63.47%
Promoter Δ QoQ-0.01 pp
Public36.53%
FII7.63%
DII21.94%
Pledged20.65%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)1,374.81,421.61,626.01,794.2
YoY chg+20.0%+21.5%+24.8%+32.5%
Net profit (₹ Cr)273.8266.7334.2388.1
YoY chg+17.6%+18.4%+30.9%+49.2%
Net margin19.9%18.8%20.6%21.6%
EPS21.9121.3426.7231.03

Shareholding over time

By quarter

30 Sept 2026 · promoter 63.47% · public 36.53%
30 Sept 2021: promoter 70.34%31 Dec 2021: promoter 70.34%31 Mar 2022: promoter 70.48%30 Jun 2022: promoter 70.48%30 Sept 2022: promoter 70.48%31 Dec 2022: promoter 66.11%31 Mar 2023: promoter 66.11%19 Apr 2023: promoter 66.21%30 Jun 2023: promoter 66.21%30 Sept 2023: promoter 66.21%31 Dec 2023: promoter 66.21%31 Mar 2024: promoter 66.21%30 Jun 2024: promoter 66.27%30 Sept 2024: promoter 66.26%31 Dec 2024: promoter 66.26%31 Mar 2025: promoter 66.26%30 Jun 2025: promoter 66.26%30 Sept 2025: promoter 66.25%31 Dec 2025: promoter 66.25%31 Mar 2026: promoter 66.25%30 Jun 2026: promoter 63.48%30 Sept 2026: promoter 63.47%
2021-092026-09
  • Promoter
  • Public and others
Promoter
63.47%
Public
36.53%
Promoter change
-0.01 pp
Filed
13 Oct 2026
FII
7.63%
DII
21.94%
Promoter pledged
20.65%

Who the public is

Mutual funds
17.95%

-0.15 pp QoQ

Insurance
3.58%

+0.29 pp QoQ

FPI
7.62%

-0.06 pp QoQ

Retail ≤ ₹2L
5.57%

-0.14 pp QoQ

HNI > ₹2L
0.64%

+0.09 pp QoQ

NRI
0.29%

-0.01 pp QoQ

Bodies corporate
0.18%

+0.01 pp QoQ

Shareholders
61,923

-5.2% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Rajesh M Agrawal, trustee Rajesh Agrawal TrustPromoter · Individual14.47%
Yogesh M Agrawal, trustee Yogesh Agrawal TrustPromoter · Individual14.47%
Aayush M Agrawal, trustee Aayush Agrawal TrustPromoter · Individual11.29%
Ravi P Agrawal, trustee Ravi Agrawal TrustPromoter · Individual10.24%
Gabs Investments Pvt LtdPromoter · Corporate10.07%
Kotak Flexicap FundMutual fund3.22%
Uti-Flexi Cap FundMutual fund2.97%
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap FundMutual fund2.79%
Ganga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi AgrawalPromoter · Individual2.68%
Aditya Birla Sun Life Mutual Fund - Aditya Birla Sun Life Midcap FundMutual fund2.22%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 28 Jun 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹32.00₹32.00
FY2025-261₹28.00₹28.00
FY2024-251₹28.00₹28.00
FY2023-242₹51.00₹51.00
FY2022-231₹7.00₹7.00
FY2021-221₹9.50₹6.33
FY2020-211₹9.50₹6.33
FY2019-201₹13.00₹8.67
FY2018-191₹9.00₹6.00
FY2016-172₹13.00₹8.67
FY2015-162₹14.00₹9.33
FY2014-151₹10.00₹2.67
FY2013-141₹6.25₹1.11
FY2012-131₹7.50₹0.67
Ex-dateRecord dateDeclaredAdjusted
5 Aug 2026—₹32.00₹32.00
10 Nov 2025—₹28.00₹28.00
6 Nov 2024—₹28.00₹28.00
8 Feb 2024—₹26.00₹26.00
4 Aug 2023—₹25.00₹25.00
11 Nov 2022—₹7.00₹7.00
9 Nov 2021—₹9.50₹6.33
12 Nov 2020—₹9.50₹6.33
15 Nov 2019—₹13.00₹8.67
9 Nov 2018—₹9.00₹6.00
23 Mar 2017—₹7.00₹4.67
7 Nov 2016—₹6.00₹4.00
17 Mar 2016—₹8.00₹5.33
25 Jun 2015—₹6.00₹4.00
24 Jul 2014—₹10.00₹2.67
18 Jul 2013—₹6.25₹1.11
28 Jun 2012—₹7.50₹0.67

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
412
46 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
29 Jun 2026A V JAYAKUMAREmployeeSell2.5K₹81.8L3,271.006.3K → 3.8K0.00%0.00 pp7(2)told 29 Jun 2026
29 Jun 2026JAGDISH DWARKADAS JOSHIEmployeeSell725₹24.1L3,329.007.5K → 6.8K0.01%-0.00 pp7(2)told 29 Jun 2026
9 Jun 2026RAVI P AGRAWAL, TRUSTEE RAVI AGRAWAL TRUSTPromoterSell34.50L₹1,024.0Cr2,968.001.62Cr → 1.28Cr10.24%-2.76 pp7(2)told 9 Jun 2026
13 Mar 2026SHAILESH R SINGHOtherSell607₹18.8L3,100.1814.1K → 13.5K0.01%-0.00 pp7(2)told 13 Mar 2026
29 Dec 2025SHAILESH R SINGHOtherSell750₹20.3L2,713.0814.9K → 14.1K0.01%-0.00 pp7(2)told 29 Dec 2025
13 Nov 2025SHAILESH R SINGHOtherSell2.0K₹51.3L2,565.4116.9K → 14.9K0.01%-0.00 pp7(2)told 13 Nov 2025
13 Nov 2025SHAILESH R SINGHOtherSell3.0K₹75.9L2,528.4319.9K → 16.9K0.01%-0.00 pp7(2)told 13 Nov 2025
26 Jun 2025SHAILESH R SINGHOtherSell900₹23.2L2,574.4319.8K → 18.9K0.02%-0.00 pp7(2)told 26 Jun 2025
28 Feb 2025VANDANA SHAILESH SINGHOtherSell548₹14.9L2,722.45548 → —0.00%7(2)told 27 Feb 2025
31 Dec 2024J K TRIPATHIOtherSell100₹3.0L2,950.00700 → 6000.00%0.00 pp7(2)told 31 Dec 2024
31 Dec 2024J K TRIPATHIOtherSell100₹2.9L2,895.00800 → 7000.00%0.00 pp7(2)told 31 Dec 2024
31 Dec 2024J K TRIPATHIOtherSell100₹3.0L3,000.00900 → 8000.00%0.00 pp7(2)told 31 Dec 2024
31 Dec 2024J K TRIPATHIOtherSell49₹1.5L3,060.00949 → 9000.00%0.00 pp7(2)told 31 Dec 2024
31 Dec 2024J K TRIPATHIOtherSell51₹1.6L3,100.001.0K → 9490.00%0.00 pp7(2)told 31 Dec 2024
6 Sept 2024SEEMA AGRAWALRelativeSell5.0K₹1.6Cr3,287.2326.0K → 21.0K0.02%-0.00 pp7(2)told 6 Sept 2024
6 Sept 2024ARVIND K AGRAWALOtherSell6.0K₹2.0Cr3,293.6223.3K → 17.3K0.01%-0.00 pp7(2)told 6 Sept 2024
4 Sept 2024J K TRIPATHIOtherSell100₹3.2L3,200.001.1K → 1.0K0.00%0.00 pp7(2)told 4 Sept 2024
4 Sept 2024J K TRIPATHIOtherSell100₹3.0L2,991.031.2K → 1.1K0.00%0.00 pp7(2)told 4 Sept 2024
4 Sept 2024J K TRIPATHIOtherSell200₹5.6L2,808.53900 → 7000.00%0.00 pp7(2)told 4 Sept 2024
9 Aug 2024JAGDISH DWARKADAS JOSHIOtherSell2.0K₹59.0L2,952.468.8K → 6.8K0.01%-0.00 pp7(2)told 9 Aug 2024
14 Jun 2024SHAILESH R SINGHOtherSell1.2K₹29.0L2,416.3320.1K → 18.9K0.02%-0.00 pp7(2)told 12 Jun 2024
14 Jun 2024SHAILESH R SINGHOtherSell1.8K₹43.6L2,423.5421.9K → 20.1K0.02%-0.00 pp7(2)told 12 Jun 2024
16 Feb 2024JAGDISH DWARKADAS JOSHIOtherSell1.0K₹21.5L2,151.359.0K → 8.0K0.01%-0.00 pp7(2)told 15 Feb 2024
21 Dec 2023J K TRIPATHIOtherBuy20₹38,7211,936.05505 → 5250.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy30₹55,5391,851.30475 → 5050.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy5₹9,4151,883.00470 → 4750.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy5₹9,4001,880.00465 → 4700.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy5₹9,3951,879.00460 → 4650.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy5₹9,3801,876.00455 → 4600.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy5₹9,3901,878.00450 → 4550.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy25₹46,6251,865.00425 → 4500.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy50₹90,4331,808.66375 → 4250.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy25₹45,1411,805.64350 → 3750.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy125₹2.3L1,823.05225 → 3500.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy27₹49,3191,826.63198 → 2250.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy50₹94,0171,880.34650 → 7000.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy50₹93,7501,875.00600 → 6500.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy50₹94,5451,890.90550 → 6000.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy25₹48,7781,951.12525 → 5500.00%0.00 pp7(2)told 19 Dec 2023
21 Dec 2023J K TRIPATHIOtherBuy70₹1.3L1,833.53128 → 1980.00%0.00 pp7(2)told 19 Dec 2023
20 Dec 2023JAGDISH DWARKADAS JOSHIOtherSell926₹17.5L1,892.0010.2K → 9.3K0.01%-0.00 pp7(2)told 20 Dec 2023
12 Jun 2023Satish AgrawalEmployeeSell1.1K₹16.5L1,498.3493.0K → 91.9K0.07%-0.00 pp7(2)told 8 Jun 2023
9 Jun 2023MATHEW PAUL EDELSONOtherSell1.5K₹20.6L1,370.941.5K → —0.00%7(2)told 7 Jun 2023
29 May 2023JOHN GERARD ADAMSOtherSell8.3K₹1.0Cr1,257.518.3K → —0.00%7(2)told 29 May 2023
25 May 2023JEFFREY WILLIAM BURDOtherSell2.3K₹28.8L1,279.352.3K → —0.00%7(2)told 24 May 2023
22 May 2023Dr. Shailesh SinghOtherSell1.1K₹13.8L1,289.2023.0K → 21.9K0.02%-0.00 pp7(2)told 22 May 2023

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 9 Jun 2026

CSV
12 of 68 deals
By year
DateDealClientQuantityPriceValue
9 Jun 2026Sell · block, also bulkRAVI AGRAWAL TRUST34.50L2,968.00₹1,024.0Cr
9 Jun 2026Buy · block, also bulkKOTAK MAHINDRA MUTUAL FUND21.02L2,968.00₹624.0Cr
9 Jun 2026Buy · blockADITYA BIRLA SUN LIFE MUTUAL FUND13.48L2,968.00₹400.0Cr
22 Dec 2022Sell · block, also bulkAAYUSH AGRAWAL TRUST38.54L1,160.10₹447.1Cr
22 Dec 2022Sell · block, also bulkRAVI AGRAWAL TRUST16.39L1,160.10₹190.1Cr
22 Dec 2022Buy · block, also bulkICICI PRUDENTIAL MUTUAL FUND10.86L1,160.10₹126.0Cr
22 Dec 2022Buy · block, also bulkNIPPON INDIA MUTUAL FUND7.15L1,160.10₹83.0Cr
22 Dec 2022Buy · blockADITYA BIRLA SUN LIFE MUTUAL FUND5.01L1,160.10₹58.1Cr
22 Dec 2022Buy · blockGRANDEUR PEAK INTERNATIONAL STALWARTS FUND4.42L1,160.10₹51.3Cr
22 Dec 2022Buy · blockFRANKLIN TEMPLETON INVESTMENT FUNDS - TEMPLETON ASIAN SMALLER COMPANIES FUND3.44L1,160.10₹39.9Cr
22 Dec 2022Buy · blockTATA AIA LIFE INSURANCE COMPANY LIMITED3.23L1,160.10₹37.5Cr
22 Dec 2022Buy · blockUTI MUTUAL FUND3.05L1,160.10₹35.3Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to AJANTPHARM.

Price band: 20% · not in the F&O ban · 3.7% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: band changes · MWPL.

Every stock on this session →

Futures & options · 27 Jun 2019

CSV

Long unwinding — price down as positions closed — longs exiting.

Futures OI
51.0K

₹3.3Cr

OI change
-72.02%
Basis
-0.15%
Rollover
0.0%
PCR (OI)
0.53
PCR (volume)
1.03
Front settle
956.10
Lot size
—

shares

Futures volume
450

contracts

Futures trades
—
Futures value
₹21.4Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations1,105.21,054.11,144.91,186.61,146.11,170.41,302.71,353.71,374.81,421.61,626.01,794.2
Other income13.635.526.519.530.418.126.359.325.061.470.937.4
Total income1,118.71,089.61,171.41,206.11,176.61,188.51,329.01,413.11,399.81,483.11,696.91,831.6
Total expenses827.8811.5849.3915.9869.2919.1997.91,072.31,041.21,136.01,250.11,296.4
└ Finance costs2.51.50.76.07.96.15.33.45.12.43.22.2
└ Depreciation34.334.334.034.436.039.841.343.043.545.444.547.6
Profit before tax290.9278.0322.1290.2307.4269.4331.1340.8358.6347.1446.8535.2
Tax expense80.975.376.473.874.544.275.880.684.880.4112.6147.0
Net profit210.0202.7245.8216.5232.9225.3255.3260.2273.8266.7334.2388.1
EPS16.6816.1019.5417.2718.6018.0020.4420.8321.9121.3526.7531.07
Net margin19.00%19.23%21.47%18.24%20.32%19.25%19.60%19.22%19.91%18.76%20.56%21.63%
PBT margin26.32%26.38%28.13%24.46%26.82%23.02%25.42%25.18%26.08%24.42%27.48%29.83%
Tax rate27.80%27.09%23.70%25.41%24.24%16.39%22.89%23.66%23.66%23.17%25.20%27.47%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 30 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets4,679.04,433.24,638.44,790.55,015.05,672.46,154.86,425.3
Current assets2,825.22,562.82,722.12,785.92,829.73,393.63,735.43,823.3
└ Cash & equivalents329.8261.8129.563.9175.189.8103.390.2
└ Other bank balances1.11.01.31.01.11.31.51.8
└ Current investments510.3212.8330.1677.0438.7849.0559.9588.1
└ Trade receivables1,056.91,141.41,246.81,016.41,182.71,447.51,853.91,863.6
└ Inventories815.6785.8828.4845.7903.9812.1938.5966.6
Total equity3,388.03,481.93,567.43,677.03,790.34,315.04,527.14,858.3
└ Attributable to owners3,388.03,481.93,567.43,677.03,790.34,315.04,527.14,858.3
└ Non-controlling interest0.00.00.00.0—0.00.00.0
└ Share capital25.325.325.325.125.125.125.125.1
Borrowings1.40.91.52.42.6201.7212.0104.3
└ Current0.20.91.50.02.6201.7212.0104.3
└ Non-current1.30.00.02.40.00.00.00.0
Trade payables422.8361.1463.2420.9454.2430.1544.3571.2
Current liabilities1,139.3799.3895.3536.9996.11,159.81,415.81,342.8
Total liabilities1,291.0951.41,071.01,113.61,224.71,357.41,627.81,567.0
Net debt(839.7)(474.7)(459.3)(739.5)(612.4)(738.4)(452.6)(575.7)
Debt / equity0.000.000.000.000.000.050.050.02
Current ratio2.483.213.045.192.842.932.642.85

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow791.8399.0785.1776.51,157.2283.9529.2749.5
└ Capex(174.5)(61.2)(152.4)(149.7)(317.9)(173.5)(365.2)(259.0)
Free cash flow617.3337.9632.7626.7839.3110.5164.0490.5
Investing cash flow(559.6)245.965.4(475.7)(376.5)(548.9)(428.9)(249.1)
Financing cash flow(107.9)(713.7)(1,051.1)(366.0)(733.4)181.5(167.9)(514.7)
└ Dividends paid(89.7)(314.8)(642.2)0.0(349.4)(0.0)(349.7)(399.6)
└ Buybacks(1.4)(389.2)(389.2)(353.6)(353.0)0.00.00.0
Net change in cash123.5(68.0)(200.3)(65.6)45.6(85.3)(67.7)(14.3)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

AJANTPHARM at a glance

  • AJANTPHARM closed at ₹3,317.7 on 20 Nov 2026, +1.45% on the day, +31.5% over one year, 12.6% below its 52-week high of ₹3,796.
  • Delivery was 57.7% of traded quantity on 20 Nov 2026, the 81st percentile of its own 3,629 sessions with a reading (20-session average 55.2%, 1-year average 53.6%).
  • Market capitalisation is ₹41,458 crore at a trailing P/E of 32.8 (trailing EPS ₹101.06).
  • Q2 FY27 results (consolidated, filed 30 Oct 2026): revenue ₹1,794 crore (+32.5% year on year), net profit ₹388 crore (+49.2%); the price moved +1.4% on the first session after.
  • Promoters held 63.47% at 30 Sept 2026, down 0.01 percentage points on the previous filing, with 20.65% of promoter shares pledged.
  • Q3 FY27 results are expected between 30 Jan 2027 and 2 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE031B01049
SeriesEQ
Listed29 May 2000
NSE market cap · 17 Nov 2026₹41,393 Cr
Free-float market cap (NSE)₹15,061 Cr
Shares outstanding (NSE)12.50Cr
History from5 Jun 2000
Sessions6,578
Turnover rank#387

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.